Luminate: Phase II started

Allegro began a double-blind, U.S. Phase II trial comparing 1, 2 and 3 mg intravitreal Luminate vs. Avastin bevacizumab or focal laser photocoagulation in 150 patients. Senju has exclusive rights to ...